Mette Haugen

552 total citations
20 papers, 382 citations indexed

About

Mette Haugen is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mette Haugen has authored 20 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 7 papers in Molecular Biology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mette Haugen's work include Autoimmune Neurological Disorders and Treatments (16 papers), Myasthenia Gravis and Thymoma (5 papers) and Genetics and Neurodevelopmental Disorders (5 papers). Mette Haugen is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (16 papers), Myasthenia Gravis and Thymoma (5 papers) and Genetics and Neurodevelopmental Disorders (5 papers). Mette Haugen collaborates with scholars based in Norway and France. Mette Haugen's co-authors include Christian A. Vedeler, Anette Storstein, Sissel E. Monstad, Manja Schubert, Jan Aarseth, L. Drivsholm, Bethan Lang, Angela Vincent, Debabrata Panja and Clive R. Bramham and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Neurology.

In The Last Decade

Mette Haugen

20 papers receiving 379 citations

Peers

Mette Haugen

NEURO

CMN

GENET

EPIDE

J.‐C. Antoine France

Yoshihiro Tanno Japan

Maria Blazo United States

Anne‐Laurie Pinto France

Aditya G. Shivane United Kingdom

Ramita Dewan United States

Marylène Rousseau Canada

Setareh Sadat Banihosseini Iran

Tim-Rasmus Kiehl United States

Philippe Kerschen France

J.‐C. Antoine France

Mette Haugen

436 ×1.5

NEURO

100 ×0.8

176 ×1.9

CMN

55 ×0.8

GENET

48 ×0.9

EPIDE

Citations per year, relative to Mette Haugen Mette Haugen (= 1×) peers J.‐C. Antoine

Countries citing papers authored by Mette Haugen

Since Specialization

Citations

This map shows the geographic impact of Mette Haugen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mette Haugen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mette Haugen more than expected).

Fields of papers citing papers by Mette Haugen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mette Haugen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mette Haugen. The network helps show where Mette Haugen may publish in the future.

Co-authorship network of co-authors of Mette Haugen

This figure shows the co-authorship network connecting the top 25 collaborators of Mette Haugen. A scholar is included among the top collaborators of Mette Haugen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mette Haugen. Mette Haugen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haugen, Mette, et al.. (2023). A cerebellar degeneration‐related protein 2‐like cell‐based assay for anti‐Yo detection in patients with paraneoplastic cerebellar degeneration. European Journal of Neurology. 30(6). 1727–1733. 4 indexed citations

Fernø, Martin A., et al.. (2023). Room-Scale CO2 Injections in a Physical Reservoir Model with Faults. Transport in Porous Media. 151(5). 913–937. 18 indexed citations

Haugen, Mette, et al.. (2023). Case report: Seropositive myasthenia gravis complicated by limbic encephalitis positive for antibodies to AMPAR and Lgi1. Frontiers in Neurology. 14. 1237140–1237140. 1 indexed citations

Bjerknes, Tale L., et al.. (2022). Case report: Pain in anti-DPPX encephalitis. Frontiers in Neurology. 13. 1091688–1091688. 4 indexed citations

Haugen, Mette, et al.. (2021). Expression of cerebellar degeneration-related proteins CDR2 and CDR2L in human and rat brain tissue. Journal of Neuroimmunology. 362. 577766–577766. 5 indexed citations

Haugen, Mette, et al.. (2021). CRMP5 Antibodies—Diagnostic Challenges. Frontiers in Neurology. 12. 729075–729075. 10 indexed citations

Haugen, Mette, et al.. (2021). Paraneoplastic Cerebellar Degeneration. Neurology Neuroimmunology & Neuroinflammation. 8(2). 20 indexed citations

Haugen, Mette, et al.. (2019). CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration. Annals of Neurology. 86(2). 316–321. 37 indexed citations

Haugen, Mette, et al.. (2018). Expression of the onconeural protein CDR1 in cerebellum and ovarian cancer. Oncotarget. 9(35). 23975–23986. 3 indexed citations

10.

Haugen, Mette, et al.. (2017). Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies. Cancer Immunology Immunotherapy. 66(11). 1463–1471. 29 indexed citations

11.

Schubert, Manja, Debabrata Panja, Mette Haugen, Clive R. Bramham, & Christian A. Vedeler. (2014). Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis. Acta Neuropathologica. 128(6). 835–852. 44 indexed citations

12.

Tzoulis, Charalampos, Christian A. Vedeler, Mette Haugen, et al.. (2013). Progressive striatal necrosis associated with anti-NMDA receptor antibodies. BMC Neurology. 13(1). 55–55. 20 indexed citations

13.

Ying, Ming, Mette Haugen, Anette Storstein, et al.. (2013). Avidity of onconeural antibodies is of clinical relevance. Cancer Immunology Immunotherapy. 62(8). 1393–1396. 2 indexed citations

14.

Haugen, Mette, et al.. (2013). CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration. PLoS ONE. 8(6). e66002–e66002. 39 indexed citations

15.

Storstein, Anette, et al.. (2010). Onconeural antibodies: Improved detection and clinical correlations. Journal of Neuroimmunology. 232(1-2). 166–170. 27 indexed citations

16.

Haugen, Mette, Jane Kristin Nøstbakken, Sissel E. Monstad, et al.. (2010). CDR2 antigen and Yo antibodies. Cancer Immunology Immunotherapy. 60(2). 283–289. 28 indexed citations

17.

Bredholt, Geir, et al.. (2009). Antibody to CCDC104 is associated with a paraneoplastic antibody to CDR2 (anti-Yo). Cancer Immunology Immunotherapy. 59(2). 231–237. 4 indexed citations

18.

Haugen, Mette, et al.. (2008). Proteasome Antibodies in Patients with Cancer or Multiple Sclerosis. Scandinavian Journal of Immunology. 67(4). 400–403. 5 indexed citations

19.

Bredholt, Geir, Anette Storstein, Mette Haugen, et al.. (2006). Detection of Autoantibodies to the BTB‐kelch Protein KLHL7 in Cancer Sera. Scandinavian Journal of Immunology. 64(3). 325–335. 12 indexed citations

20.

Monstad, Sissel E., L. Drivsholm, Anette Storstein, et al.. (2004). Hu and Voltage-Gated Calcium Channel (VGCC) Antibodies Related to the Prognosis of Small-Cell Lung Cancer. Journal of Clinical Oncology. 22(5). 795–800. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact